Brendan Haberle’s practice focuses on technology transactions within the life sciences industry. Brendan leverages his training and prior experience in laboratory science and technical analysis to advise companies on technology licensing, collaborations and other strategic intellectual property transactions, as well as regarding intellectual property matters within corporate transactions such as public offerings and mergers and acquisitions.
Download full bio